RT Journal Article
SR Electronic
T1 Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.11.22268631
DO 10.1101/2022.01.11.22268631
A1 Flávio de Azevedo Figueiredo
A1 Lucas Emanuel Ferreira Ramos
A1 Rafael Tavares Silva
A1 Magda Carvalho Pires
A1 Daniela Ponce
A1 Rafael Lima Rodrigues de Carvalho
A1 Alexandre Vargas Schwarzbold
A1 Amanda de Oliveira Maurílio
A1 Ana Luiza Bahia Alves Scotton
A1 Andresa Fontoura Garbini
A1 Bárbara Lopes Farace
A1 Bárbara Machado Garcia
A1 Carla Thais Cândida Alves da Silva
A1 Christiane Corrêa Rodrigues Cimini
A1 Cíntia Alcantara de Carvalho
A1 Cristiane dos Santos Dias
A1 Daniel Vitorio Silveira
A1 Euler Roberto Fernandes Manenti
A1 Evelin Paola de Almeida Cenci
A1 Fernando Anschau
A1 Fernando Graça Aranha
A1 Filipe Carrilho de Aguiar
A1 Frederico Bartolazzi
A1 Giovanna Grunewald Vietta
A1 Guilherme Fagundes Nascimento
A1 Helena Carolina Noal
A1 Helena Duani
A1 Heloisa Reniers Vianna
A1 Henrique Cerqueira Guimarães
A1 Joice Coutinho de Alvarenga
A1 José Miguel Chatkin
A1 Júlia Parreiras Drumond de Moraes
A1 Juliana Machado Rugolo
A1 Karen Brasil Ruschel
A1 Karina Paula Medeiros Prado Martins
A1 Luanna Silva Monteiro Menezes
A1 Luciana Siuves Ferreira Couto
A1 Luís César de Castro
A1 Luiz Antônio Nasi
A1 Máderson Alvares de Souza Cabral
A1 Maiara Anschau Floriani
A1 Maíra Dias Souza
A1 Maira Viana Rego Souza e Silva
A1 Marcelo Carneiro
A1 Mariana Frizzo de Godoy
A1 Maria Aparecida Camargos Bicalho
A1 Maria Clara Pontello Barbosa Lima
A1 Matheus Carvalho Alves Nogueira
A1 Matheus Fernandes Lopes Martins
A1 Milton Henriques Guimarães-Júnior
A1 Natália da Cunha Severino Sampaio
A1 Neimy Ramos de Oliveira
A1 Patricia Klarmann Ziegelmann
A1 Pedro Guido Soares Andrade
A1 Pedro Ledic Assaf
A1 Petrônio José de Lima Martelli
A1 Polianna Delfino Pereira
A1 Raphael Castro Martins
A1 Rochele Mosmann Menezes
A1 Saionara Cristina Francisco
A1 Silvia Ferreira Araújo
A1 Talita Fischer Oliveira
A1 Thainara Conceição de Oliveira
A1 Thaís Lorenna Souza Sales
A1 Yuri Carlotto Ramires
A1 Milena Soriano Marcolino
YR 2022
UL http://medrxiv.org/content/early/2022/01/13/2022.01.11.22268631.abstract
AB Background Acute kidney injury (AKI) is frequently associated with COVID-19 and the need for kidney replacement therapy (KRT) is considered an indicator of disease severity. This study aimed to develop a prognostic score for predicting the need for KRT in hospitalized COVID-19 patients.Methods This study is part of the multicentre cohort, the Brazilian COVID-19 Registry. A total of 5,212 adult COVID-19 patients were included between March/2020 and September/2020. We evaluated four categories of predictor variables: (1) demographic data; (2) comorbidities and conditions at admission; (3) laboratory exams within 24 h; and (4) the need for mechanical ventilation at any time during hospitalization. Variable selection was performed using generalized additive models (GAM) and least absolute shrinkage and selection operator (LASSO) regression was used for score derivation. The accuracy was assessed using the area under the receiver operating characteristic curve (AUC-ROC). Risk groups were proposed based on predicted probabilities: non-high (up to 14.9%), high (15.0 – 49.9%), and very high risk (≥ 50.0%).Results The median age of the model-derivation cohort was 59 (IQR 47-70) years, 54.5% were men, 34.3% required ICU admission, 20.9% evolved with AKI, 9.3% required KRT, and 15.1% died during hospitalization. The validation cohort had similar age, sex, ICU admission, AKI, required KRT distribution and in-hospital mortality. Thirty-two variables were tested and four important predictors of the need for KRT during hospitalization were identified using GAM: need for mechanical ventilation, male gender, higher creatinine at admission, and diabetes. The MMCD score had excellent discrimination in derivation (AUROC = 0.929; 95% CI 0.918–0.939) and validation (AUROC = 0.927; 95% CI 0.911–0.941) cohorts an good overall performance in both cohorts (Brier score: 0.057 and 0.056, respectively). The score is implemented in a freely available online risk calculator (https://www.mmcdscore.com/).Conclusion The use of the MMCD score to predict the need for KRT may assist healthcare workers in identifying hospitalized COVID-19 patients who may require more intensive monitoring, and can be useful for resource allocation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported in part by Minas Gerais State Agency for Research and Development (Fundação de Amparo à Pesquisa do Estado de Minas Gerais –FAPEMIG) [grant number APQ–00208–20] and National Institute of Science and Technology for Health Technology Assessment (Instituto de Avaliação de Tecnologias em Saúde–IATS)/ National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Científico e Tecnológico –CNPq) [grant number 465518/2014–1].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by Brazilian National Committee for Ethics in Research - CONEP (CAAE - Certificate of presentation of Ethical Appreciation: 30350820.5.1001.0008)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsAKIacute kidney injuryARDSacute respiratory distress syndromeAUROCarea under the receiver operating characteristicBMIbody mass indexBPM1beats per minuteBPM2breaths per minuteCIconfidence intervalCOPDchronic obstructive pulmonary diseaseCOVID-19Coronavirus disease 19GAMgeneralized additive modelsGBTgradient boosted treesICUintensive care unitIL-6interleukin-6IQRinterquartile rangeKDIGOKidney Disease Improving Global OutcomesKRTkidney replacement therapyLASSOleast absolute shrinkage and selection operatorMICEmultiple imputation with chained equationsMMCDmechanical ventilation, male, creatinine, diabetesMVmechanical ventilationpCO2partial pressure of carbon dioxidePEEPpositive end-expiratory pressurePMMPredictive mean matchingPO2partial pressure of oxygenPROBASTPrediction model Risk Of Bias Assessment ToolREDCapResearch Electronic Data CaptureSBPsystolic blood pressureSF ratioSpO2/FiO2 ratioSOFASepsis-related Organ Failure AssessmentTRIPODTransparent Reporting of a Multivariable Prediction Model for Individual Prediction or DiagnosisUSAUnited States of America